Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
09 Feb 2021
09 Feb 2021
Historique:
entrez:
17
2
2021
pubmed:
18
2
2021
medline:
18
2
2021
Statut:
epublish
Résumé
Nucleocapsid (N) protein of the SARS-CoV-2 virus packages the viral genome into well-defined ribonucleoprotein particles, but the molecular pathway is still unclear. N-protein is dimeric and consists of two folded domains with nucleic acid (NA) binding sites, surrounded by intrinsically disordered regions that promote liquid-liquid phase separation. Here we use biophysical tools to study N-protein interactions with oligonucleotides of different length, examining the size, composition, secondary structure, and energetics of the resulting states. We observe formation of supramolecular clusters or nuclei preceding growth into phase-separated droplets. Short hexanucleotide NA forms compact 2:2 N-protein/NA complexes with reduced disorder. Longer oligonucleotides expose additional N-protein interactions and multi-valent protein-NA interactions, which generate higher-order mixed oligomers and simultaneously promote growth of droplets. Phase separation is accompanied by a significant increase in protein secondary structure, different from that caused by initial NA binding, which may contribute to the assembly of ribonucleoprotein particles within molecular condensates.
Identifiants
pubmed: 33594360
doi: 10.1101/2021.02.08.430344
pmc: PMC7885910
pii:
doi:
Types de publication
Preprint
Langues
eng
Commentaires et corrections
Type : UpdateIn
Références
Sci Rep. 2017 Jul 18;7(1):5740
pubmed: 28720894
Nature. 2020 Aug;584(7819):154-156
pubmed: 32438371
Virus Res. 2004 Oct;105(2):121-5
pubmed: 15351485
Anal Chem. 2012 Nov 6;84(21):9513-9
pubmed: 23020071
Anal Chem. 2012 Jun 5;84(11):5066-73
pubmed: 22530732
Biophys Chem. 2004 Mar 1;108(1-3):165-85
pubmed: 15043928
Science. 2020 Aug 21;369(6506):1010-1014
pubmed: 32540901
Proteomics. 2005 Mar;5(4):925-37
pubmed: 15759315
Cryst Growth Des. 2010 Nov 15;10(12):5007-5019
pubmed: 21132117
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Microbes Infect. 2020 May - Jun;22(4-5):188-194
pubmed: 32302675
Nat Commun. 2021 Jan 21;12(1):502
pubmed: 33479198
Mol Cell. 2020 Dec 17;80(6):1078-1091.e6
pubmed: 33290746
J Biol Chem. 2009 Feb 20;284(8):5229-39
pubmed: 19106108
Elife. 2018 Feb 09;7:
pubmed: 29424691
Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):E3095-103
pubmed: 26038575
Curr Top Med Chem. 2016;16(10):1154-66
pubmed: 26329615
Proc Natl Acad Sci U S A. 2020 Dec 29;117(52):33254-33262
pubmed: 33318217
Nat Commun. 2020 Nov 18;11(1):5885
pubmed: 33208793
Cell Res. 2020 Dec;30(12):1143-1145
pubmed: 32901111
Viruses. 2014 Aug 07;6(8):2991-3018
pubmed: 25105276
Biochem Biophys Res Commun. 2004 Apr 2;316(2):476-83
pubmed: 15020242
J Biol Chem. 2005 Jun 17;280(24):23280-6
pubmed: 15849181
Biochemistry. 2005 Nov 22;44(46):15351-8
pubmed: 16285739
Acta Pharm Sin B. 2020 Jul;10(7):1228-1238
pubmed: 32363136
J Virol. 2009 Mar;83(5):2255-64
pubmed: 19052082
Protein Cell. 2017 Mar;8(3):219-224
pubmed: 28044277
Cell Discov. 2021 Jan 21;7(1):5
pubmed: 33479219
PLoS One. 2013 May 23;8(5):e65045
pubmed: 23717688
Methods. 2015 Apr;76:137-148
pubmed: 25477226
Nat Commun. 2020 Nov 27;11(1):6041
pubmed: 33247108
Immunity. 2020 Sep 15;53(3):524-532.e4
pubmed: 32783920
PLoS One. 2013 Dec 17;8(12):e83439
pubmed: 24358283
Future Virol. 2018 Jun;13(6):405-430
pubmed: 32201497
Protein Sci. 2020 Sep;29(9):1890-1901
pubmed: 32654247
Adv Virus Res. 2006;66:193-292
pubmed: 16877062
Antiviral Res. 2014 Mar;103:39-50
pubmed: 24418573
Mol Cell. 2020 Dec 17;80(6):1092-1103.e4
pubmed: 33248025
Cell. 2020 Oct 29;183(3):730-738.e13
pubmed: 32979942
Cell. 2019 Jan 24;176(3):419-434
pubmed: 30682370
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15193-15199
pubmed: 32522874
FASEB J. 2020 Aug;34(8):9832-9842
pubmed: 32562316
Front Microbiol. 2020 Aug 12;11:1862
pubmed: 32903425
Rep Prog Phys. 2018 Apr;81(4):046601
pubmed: 29313527
Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4408-E4415
pubmed: 28507126
J Chem Phys. 2006 Apr 21;124(15):154902
pubmed: 16674260
J Mol Biol. 2007 May 11;368(4):1075-86
pubmed: 17379242
Virology. 2019 Nov;537:198-207
pubmed: 31505321
J Mol Biol. 2008 Jul 18;380(4):608-22
pubmed: 18561946
Biochem Biophys Res Commun. 2021 Jan 29;538:54-62
pubmed: 33039147
Nature. 2020 Oct;586(7830):516-527
pubmed: 32967006
J Biomol Struct Dyn. 2020 Nov 3;:1-14
pubmed: 33140703
Trends Microbiol. 2011 Dec;19(12):606-13
pubmed: 22000206
PLoS Pathog. 2020 Dec 2;16(12):e1009100
pubmed: 33264373
Cell Rep. 2020 Jul 21;32(3):107940
pubmed: 32668216
Biochem Biophys Res Commun. 2020 Jun 30;527(3):618-623
pubmed: 32416961
Biophys J. 2010 May 19;98(9):2005-13
pubmed: 20441765
J Gen Virol. 1978 Jun;39(3):545-9
pubmed: 207820
Biophys J. 2021 Jan 19;120(2):370-378
pubmed: 33340542
Cell. 2020 Jul 23;182(2):417-428.e13
pubmed: 32526208
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
J Immunol. 2008 Nov 1;181(9):6337-48
pubmed: 18941225
J Biomed Sci. 2006 Jan;13(1):59-72
pubmed: 16228284
Nucleic Acids Res. 2018 Jul 2;46(W1):W315-W322
pubmed: 29893907
Cell. 2020 Sep 17;182(6):1560-1573.e13
pubmed: 32783916